Related references
Note: Only part of the references are listed.Loss of Metallothionein Predisposes Mice to Diethylnitrosamine-Induced Hepatocarcinogenesis by Activating NF-κB Target Genes
Sarmila Majumder et al.
CANCER RESEARCH (2010)
The Presence of Aberrant DNA Methylation in Noncancerous Esophageal Mucosae in Association With Smoking History A Target for Risk Diagnosis and Prevention of Esophageal Cancers
Daiji Oka et al.
CANCER (2009)
Downregulated expression of metallothionein and its clinicopathological significance in hepatocellular carcinoma
Xia Tao et al.
HEPATOLOGY RESEARCH (2007)
Metallothionein expression is suppressed in primary human hepatocellular carcinomas and is mediated through inactivation of CCAAT/enhancer binding protein α by phosphatidylinositol 3-kinase signaling cascade
Jharna Datta et al.
CANCER RESEARCH (2007)
Nuclear factor-κB in cancer development and progression
Michael Karin
NATURE (2006)
Metallothionein mediates the level and activity of nuclear factor κB in murine fibroblasts
HL Butcher et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Metallothionein expression in human neoplasia
SE Theocharis et al.
HISTOPATHOLOGY (2004)
Expression of human metallothionein III and its metalloabsorption capability in Escherichia coli
WJ Zheng et al.
PREPARATIVE BIOCHEMISTRY & BIOTECHNOLOGY (2004)
Role of Rel/NF-κB transcription factors in apoptosis of human hepatocellular carcinoma cells
PJ Chiao et al.
CANCER (2002)
Zinc-induced activation of the human cytomegalovirus major immediate-early promoter is mediated by metallothionein and nuclear factor-κB
M Kanekiyo et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2001)
Augmented humoral immune function in metallothionein-null mice
KC Crowthers et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2000)
Share Paper
